Boreal Genomics Company
Boreal develops research tools and diagnostic tests based on the monitoring of tumor mutations from cell-free DNA in plasma.
At Boreal, we are committed to developing new technologies for blood-based detection and monitoring of circulating tumor DNA.
We are a team of specialists in molecular biology, engineering and physics with a passion to develop technology that advances next-generation sequencing to help cancer researchers and clinicians transform patient care through earlier detection and monitoring of cancer.
Through our first-generation SCODA platform technologies and our recent developments in Linked Molecule chemistries, Boreal is committed to creating faster, more efficient, and practical assays for routine clinical use.
At Boreal, we are committed to developing new technologies for blood-based detection and monitoring of circulating tumor DNA.
We are a team of specialists in molecular biology, engineering and physics with a passion to develop technology that advances next-generation sequencing to help cancer researchers and clinicians transform patient care through earlier detection and monitoring of cancer.
Through our first-generation SCODA platform technologies and our recent developments in Linked Molecule chemistries, Boreal is committed to creating faster, more efficient, and practical assays for routine clinical use.
Technology:
Personalized Diagnostics
Industry:
Precision Medicine
Headquarters:
Los Altos
Founded Date:
2007
Employees Number:
11-50
Funding Status:
Late Stage Venture
Register and Claim Ownership